finanznachrichten.de
Positivewww.finanznachrichten.de · · DE
68811236 original research nanorepro ag von nuways ag buy 023
RegulatoryForests Rivers OceansHealthMedical
Executive Summary
AI-generatedNuWays AG issued an original research report recommending a 'BUY' rating for NanoRepro AG, setting a target price of EUR 4.3 based on recent developments. The core focus is NanoRepro converting its distribution license for FiberSense's Continuous Glucose Monitoring (CGM) technology into an equity stake in FiberSense. This transaction, coupled with bridge financing, suggests potential value creation for NanoRepro.
Key Insights
- NuWays AG upgraded NanoRepro AG to a 'BUY' rating with a target price of EUR 4.3 over the next 12 months.
- NanoRepro is converting its distribution license for FiberSense's CGM technology into an equity stake in FiberSense.
- FiberSense, which develops CGM technology, received CE certification on June 10, 2026, significantly lowering its risk profile.
- The addressable market for CGM technology is projected to grow substantially from $15.3 billion in 2026 to $31.4 billion by 2031.
- Analysts suggest the transaction may create value for NanoRepro, implying a potential embedded value corresponding to 7-25% of NanoRepro's market capitalization.
Topic context
The full article is on the original publisher site.